company background image
PXS logo

Provexis AIM:PXS Stock Report

Last Price

UK£0.0065

Market Cap

UK£15.2m

7D

0%

1Y

-10.3%

Updated

20 Jan, 2025

Data

Company Financials

Provexis plc

AIM:PXS Stock Report

Market Cap: UK£15.2m

PXS Stock Overview

Develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. More details

PXS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the UK market

Earnings have declined by 5.5% per year over past 5 years

Does not have a meaningful market cap (£15M)

Does not have meaningful revenue (£1M)


My Notes

Capture your thoughts, links and company narrative

Provexis plc Competitors

Brand Architekts Group

AIM:BAR

UK£13.1m

Creightons

LSE:CRL

UK£21.9m

Venture Life Group

AIM:VLG

UK£46.4m

Revolution Beauty Group

AIM:REVB

UK£47.5m

Price History & Performance

Summary of share price highs, lows and changes for Provexis
Historical stock prices
Current Share PriceUK£0.0065
52 Week HighUK£0.008
52 Week LowUK£0.0045
Beta1.04
1 Month Change0%
3 Month Change28.71%
1 Year Change-10.34%
3 Year Change-16.67%
5 Year Change-7.14%
Change since IPO-89.72%

Recent News & Updates

Recent updates

We're Keeping An Eye On Provexis' (LON:PXS) Cash Burn Rate

Mar 05
We're Keeping An Eye On Provexis' (LON:PXS) Cash Burn Rate

We're Not Very Worried About Provexis' (LON:PXS) Cash Burn Rate

Jan 21
We're Not Very Worried About Provexis' (LON:PXS) Cash Burn Rate

We're Interested To See How Provexis (LON:PXS) Uses Its Cash Hoard To Grow

Jun 30
We're Interested To See How Provexis (LON:PXS) Uses Its Cash Hoard To Grow

We're Not Worried About Provexis' (LON:PXS) Cash Burn

Feb 15
We're Not Worried About Provexis' (LON:PXS) Cash Burn

We're Interested To See How Provexis (LON:PXS) Uses Its Cash Hoard To Grow

Oct 28
We're Interested To See How Provexis (LON:PXS) Uses Its Cash Hoard To Grow

Shareholder Returns

PXSGB Personal ProductsGB Market
7D0%1.5%3.5%
1Y-10.3%22.0%10.5%

Return vs Industry: PXS underperformed the UK Personal Products industry which returned 21.7% over the past year.

Return vs Market: PXS underperformed the UK Market which returned 10.6% over the past year.

Price Volatility

Is PXS's price volatile compared to industry and market?
PXS volatility
PXS Average Weekly Movement11.3%
Personal Products Industry Average Movement3.8%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.9%
10% least volatile stocks in GB Market2.6%

Stable Share Price: PXS's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: PXS's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
19992Ian Fordwww.provexis.com

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product.

Provexis plc Fundamentals Summary

How do Provexis's earnings and revenue compare to its market cap?
PXS fundamental statistics
Market capUK£15.25m
Earnings (TTM)-UK£478.29k
Revenue (TTM)UK£1.20m

12.7x

P/S Ratio

-31.9x

P/E Ratio

Is PXS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PXS income statement (TTM)
RevenueUK£1.20m
Cost of RevenueUK£780.30k
Gross ProfitUK£419.48k
Other ExpensesUK£897.77k
Earnings-UK£478.29k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0002
Gross Margin34.96%
Net Profit Margin-39.86%
Debt/Equity Ratio0%

How did PXS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 14:08
End of Day Share Price 2025/01/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Provexis plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution